-
Vaccitech Receives UK Grant to Support COVID-19 Tech Platform
contractpharma
August 28, 2020
Vaccitech's new platform induces leading antibody and cell-mediated immune responses, two arms of the immune system known to protect against disease.
-
73,000 Scientists collaborate over new COVID-19 Data Portal to speed up vaccine development
worldpharmanews
August 27, 2020
More than 73,000 users collaborate on new online platform set up by the European Open Science Cloud Initiative, where scientists share COVID-19 data and accelerate our understanding of the virus to help develop treatments and vaccines quicker.
-
COVID-19 vaccine grown in insect cells approved for clinical trials
chinadaily
August 26, 2020
A COVID-19 vaccine grown in insect cells has been approved by the National Medical Products Administration for clinical trials on Aug 21, Science Daily reported.
-
ICMR developing portal for info on COVID-19 vaccine
expresspharma
August 24, 2020
ICMR is in the process of developing a vaccine portal which will provide information related to the COVID-19 vaccine development in India and abroad, with the majority of the updates in several regional languages in addition to English.
-
First trial participant gets GSK's 5-in-1 meningitis jab
pharmatimes
August 21, 2020
Patient dosing has begun in a Phase III clinical programme investigating GlaxoSmithKline's 5-in-1 meningitis (MenABCWY) vaccine candidate compared to licensed meningococcal vaccines, Bexsero and Menveo.
-
WHO cautions against to ‘vaccine nationalism’
expresspharma
August 20, 2020
Countries putting their own interests ahead of others in trying to ensure supplies of a possible coronavirus vaccine are making the pandemic worse, said World Health Organization chief Tedros Adhanom Ghebreyesus.
-
Race to find a viable vaccine: Can Indian firms rise to the challenge?
expresspharma
August 18, 2020
Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca gives an overview of India’s capabilities to develop and manufacture vaccines.
-
Elios Cancer Vaccine Demonstrates Long-Term Survival Benefit Among High-Risk Melanoma Patients
americanpharmaceuticalreview
August 12, 2020
Elios Therapeutics announced final data from a prospective, randomized, double-blind, placebo-controlled Phase IIb clinical trial ...
-
Novavax and Serum Institute of India Announce Collaboration
contractpharma
August 11, 2020
Serum Institute gains exclusive rights to commercialize in India and non-exclusive rights to commercialize in other LMIC countries.
-
Aurobindo Pharma joins COVID-19 vaccine hunt
expresspharma
August 10, 2020
The company’s vaccine candidate has been shortlisted for BIRAC funding, will launch final product by the end of 2022.